Obesity is abnormal or excessive fat accumulation that is associated with progression of metabolic diseases including type 2 diabetes mellitus, cardiovascular disease, nonalcoholic fatty liver disease, and cancer. Gut microbiota (GM) have received much attention as essential factors in development and progression of obesity. The diversity, composition, and metabolic activity of GM are closely associated with nutrient intake and dietary pattern. Scientific evidence supports the idea that dietary pattern directly changes the GM profile; therefore, diet is a crucial component related to interactions between GM and obesity progression. A literature review showed that dietary factors such as probiotics, prebiotics, fat, fatty acids, and fiber dramatically alter the GM profile related to obesity. Furthermore, different dietary patterns result in different GM composition and activity that can contribute to amelioration of obesity.
. Effect of dietary factors on alteration of gut microbiota associated with host metabolism. LPS, lipopolysaccharide; SCFA, short chain fatty acid; F/B, Firmicutes/ Bacteroidetes. 
INTESTINAL PERMEABILITY
Many environmental factors such as diet, energy intake, and exercise can dramatically influence GM. 26, 27 Specific foods and diets can influence the abundance of different bacteria in the GM, which can affect host health. Probiotics can increase GM diversity and SCFA production and reduce T2DM and CVD. Several suggested mechanisms linking microbiota to weight changes include an increased capacity of some bacteria to extract energy, improved transfer of calories from food to host, and changes in host absorption metabolism.
PREBIOTICS AND GM
Prebiotics have been defined by the Food and Agriculture Organization (FAO) of the United Nations and WHO as "non-digestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacterial species already established in the colon, and thus improve the host health. " 28 As mentioned above, dietary prebiotics have typically been classified as nondigestible fiber that passes undigested through the upper gastrointestinal tract and stimulates and colonizes the growth of beneficial microorganisms. 29 Bindels et al. 30 reported that prebiotic ingredients include inulin, fructooligosaccharides (FOS), galactooligosaccharides, and human milk oligosaccharides. The prebiotics usually found in fruits and vegetables may lead to various health benefits in the host. 31 Among the advantages of prebiotics are promotion of ion and trace element absorption such as that of calcium, iron, and magnesium and immune system regulation by increasing Immunoglobulin A production and modulating cytokine production through mechanisms mediated by microbial metabolic products. 29 Prebiotics selectively stimulate the growth of Bifidobacteria and Lactobacillus species, which can produce greater microbial diversity within the microbiome. Through stimulation by beneficial microbiota and following fermentation, these prebiotic substrates manufacture SCFAs such as butyrate, propionate, and acetate, which are the primary energy sources of the intestine and have metabolic effects on the host. Prebiotic effects on regulation of satiety and food consumption are due to production of higher SCFA level, which improves GLP-1, PYY, and ghrelin production. 32 In addition, prebiotics also have anti-obesity effects involved in improvement of lipid metabolism by modulated GM composition. [33] [34] [35] Oligofructose-treated animals showed lower triglyceride level and adipose tissue mass. 36 Short-chain FOS treatment also ameliorates plasma lipid metabolism and hyperinsulinemia, which are associated with changes in GM composition in diet-induced obese mice. 36 Nihei et al. 37 also found that supplementation with α-cyclodextrins showed modulation of GM and SCFA production in diet-induced obese mice. These effects were associated with modulation in gene expression of lipid metabolism, including upregulation of peroxisome proliferator-activated receptor γ (PPAR-γ) and PPAR-α and downregulation of sterol regulatory element-binding protein-1c and fatty acid synthase. 37 Several clinical trials have shown a strong association between prebiotic-altered GM and obesity ( Table 1) . [38] [39] [40] [41] [42] [43] 
PROBIOTICS AND GM IN OBESITY
According to FAO/WHO, probiotics are "live microorganisms which confer a health benefit on the host when administered in adequate amounts. " 22 Recent studies have shown that Bifidobacterium species have been used as probiotic treatments in obese animal models due to a lack of pathogenicity and reduced antibiotic resistance. 33 In fact, many studies have reported that animals fed with the above-mentioned strains of Lactobacillus and Bifidobacterium showed suppression of weight gain, fat depots, and white adipose tissue compared to placebo-treated control animals. However, experimental studies clearly differ in both experimental duration and daily probiotic dose administration, which lead to different effects on body weight and/or fat mass. These probiotics showed antiobesity effects through beneficial changes in GM, lower insulin resistance, and higher satiety by modulation of the mechanism.
The effects of Lactobacillus and Bifidobacterium strains, alone or in combination, have also been well-described in obese adults, leading to reduced body weight, waist circumference, and fat depots. [44] [45] [46] [47] [48] [49] [50] Clinical studies have shown that the anti-obesogenic effects of probiotics are due to both the probiotic dose and experimental duration. L. gasseri (SBT2055 and BNR17) treatment showed reduced visceral adipose tissue and waist circumference in adults with obese tendencies or obesity. 46, 47 Pedret et al. 48 reported that Bifidobacterium animalis subspecies. Lactis CECT 8145 intervention significantly reduced waist circumference, waist circumference/height ratio, and BMI. The therapy based on L. rhamnosus CGMCC1.3724 showed weight loss in obese women in comparison with obese men. 49 High-and low-doses of probiotic mixtures (different strains of Lactobacillus and Bifidobacterium) showed similar beneficial effects on weight, BMI, and body fat mass in obese postmenopausal women, but only the high-dose group showed improvement in lipid profile. 50 In these findings, the efficacy of probiotic treatment in human studies is still unclear due to small cohort studies and shortterm follow-up. Thus, further studies are needed to identify selective probiotic strains that may produce effective changes in weight or body fat loss, either alone or in combination with other probiotic strains ( Table 2) . [44] [45] [46] [47] [48] [49] [50] 
INFLUENCE OF DIET ON GM IN OBESITY
Diet is one of the critical factors in progression of obesity and is profoundly linked to GM composition. 51 Nutrient intake and eating habits directly influence the composition, diversity, and metabolism of GM. 51, 52 Furthermore, the composition and functionality of GM respond quickly to changes in dietary composition. Several studies showed that, within 2 days after the start the dietary intervention, the GM responded and exerted changes in composition. 53 Interestingly, a healthy dietary pattern related to GM profiles exerted protective effects against development of diabetes in obese individuals. 54 Therefore, a balanced diet is required to maintain the composition and proper function of the GM. Many dietary patterns such as Western diet, vegetarian diet, gluten-free diet, and the Mediterranean diet have been shown to affect the distinct diversity of the GM that may affect host metabolism. 52 The Western diet consists of high intake of saturated fats, refined grains, sugar, salt, and high fructose corn syrup and a low intake of fiber. It is highly associated with obesity and metabolic disease. The Western diet promotes inflammation and changes the profile of the GM from healthy to the obese pattern. 55 It also has been shown to decrease the total bacteria amount as well as the beneficial Lactobacillus species (sp.) and Bifidobacterium sp. in the gut. 15 Vegetarian and vegan diets consist of plant-based foods and are rich in dietary fiber, in contrast with the Western diet. Abundant fiber in these diets promotes stable GM profile and increases the presence of lactic acid bacteria. 56 Both the vegetarian and vegan diet were shown to lower Bacteroides sp. and Bifidobacterium sp.
The GM profile of the vegan diet exerted an increase in the abun- The effects of a gluten-free diet on the GM is well known since gluten-related disease is closely associated with GM profile and metabolism. 58 The gluten-free diet lowered the abundance of Bifidobacterium sp., Lactobacillus sp., 59 and Ruminococcus bromii and an increase in Actinobacteria and a decrease in Bifidobacterium. 61, 62 The Mediterranean diet consists of vegetables, olive oil, and fruits, a moderate intake of poultry, and a low intake of red meat and dairy products. It is well known as one of the healthiest dietary patterns.
GM composition in the Mediterranean diet is high in Lactobacillus, Bifidobacterium, and Prevotella that is closely associated with the prevention of obesity and improvement of lipid and cholesterol profiles. Furthermore, the Mediterranean diet lowered Clostridium sp. that can induce inflammation. 63 The Mediterranean diet provides high dietary fiber and polyunsaturated fatty acid (PUFA) content. Dietary fatty acids can also affect GM composition. The consumption of n-3 PUFAs and conjugated linoleic acid exerted beneficial effects on the GM compared to that of n-6 PUFAs and saturated fatty acids. The GM profile in obesity changed, and was similar to that of normal individuals, by n-3 PUFA consumption. 64 The prevalence of obesity dramatically increased to 40% according to the data from the 2015 Korea National Health and Nutrition Examination Survey for Korean adults. 65 Dietary pattern and lifestyle changed dramatically with the rapid industrialization in Korea Western diet: high intake of saturated fat, refined grains, sugars, salt, and high fructose corn syrup and low intake of fiber 15, 55 Promotes inflammation and changes the GM profile to the obese pattern Decrease in total GM amount Decrease in beneficial Lactobacillus sp. and Bifidobacterium sp. Vegetarian and vegan diets: plant-based foods and rich in dietary fiber 56, 57 Increase in the abundance of protective microbiota Increase in intestinal barrier protectors (Bifidobacteria and Lactobacillus), increase in butyrate-producing bacteria (Faecalibacterium prausnitzii and Roseburia) Decrease in inflammation-inducing lipopolysaccharide producers (Escherichia coli and Enterobacter cloacae) → prevents obesity Gluten-free diet 58, 59 Decrease in Bifidobacterium sp., Lactobacillus sp., Ruminococcus bromii, and Roseburia faecis Increase in Victivallaceae and Clostridiaceae Mediterranean diet: consists of vegetables, olive oil, fruits, a moderate intake of poultry, and a low intake of red meat and dairy products 63, 64 Increase in Lactobacillus, Bifidobacterium, and Prevotella → prevents obesity and improves lipid and cholesterol profiles Decrease in Clostridium that can induce inflammation. Korean traditional diet: high consumption of vegetables and fermented foods, moderate intake of legumes and fish 65, 66 
